Lakewood-Amedex Biotherapeutics
LABTOther · NASDAQ · IPO April 23, 2026
01
Company Overview
Lakewood-Amedex Biotherapeutics is filing to list on NASDAQ Capital. Public information at this stage is limited to the IPO calendar entry; deeper detail typically becomes available closer to pricing via the company's S-1 / prospectus.
Lakewood-Amedex Biotherapeutics is going public on NASDAQ Capital on 2026-04-23. Offering 4,689,177 shares.
Recent headlines
- Lakewood-Amedex Biotherapeutics (Direct Listing)iposcoop.com
Note: This is NOT an IPO. This is a public offering – a NASDAQ Direct Listing – of up to 4.7 million of our existing shares by our registered shareholders.
- Lakewood-Amedex Biotherapeutics Announces Direct ...finance.yahoo.com
"We are pleased to announce that Lakewood-Amedex Biotherapeutics' common stock began trading on the Nasdaq Stock Market today," said Doug Manion ...
- Lakewood-Amedex Biotherapeutics Inc. Common Stock ...nasdaq.com
Stay up-to-date on Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) news with the latest updates, breaking headlines, news articles, and more from ...
- Micro-cap biotech Lakewood-Amedex Biotherapeutics files for ...renaissancecapital.com
At $8 per share, the company would be valued at about $122 million. The company's lead product candidate, Nu-3, is a broad-spectrum ...
- Lakewood-Amedex Biotherapeutics Inc. (LABT)stockanalysis.com
Lakewood-Amedex Biotherapeutics will go public soon, but the exact IPO date is still unknown. Stock Price: Pending. IPO price not available yet.
02
AI Analysis
Possible growth narrative
Sits adjacent to Other — themes that are currently drawing meaningful capital and attention.
Risks
Newly public companies typically face limited operating history disclosure, lock-up expirations, and broader market sentiment swings around IPOs.
Volatility
Expect elevated price volatility in the first weeks of trading as supply and demand find balance.
Market attention
Recently listed — monitoring early trading activity and analyst initiations.
Educational summary only. Not investment advice.
03
Related Themes
04
IPO Information
- IPO date
- April 23, 2026
- Exchange
- NASDAQ
- Status
- Recently Listed
- Industry
- Other
- Valuation
- —
- Headquarters
- —
- Attention score
- 46 / 100
- Ticker
- LABT